Viewing Study NCT01427920


Ignite Creation Date: 2025-12-25 @ 4:29 AM
Ignite Modification Date: 2026-02-21 @ 8:24 PM
Study NCT ID: NCT01427920
Status: COMPLETED
Last Update Posted: 2017-02-24
First Post: 2011-08-31
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes View
None Diabetes Mellitus, Type 2 View
Keywords: